Association between the Inflammatory Atherosclerosis Index and Non-Alcoholic Fatty Liver Disease: NHANES 2017-2020
Related Experiment Videos
Yun Jiang1, Jingying Xie1, Ying Dong1
1Department of Hepatobiliary and Pancreatic Surgery II, Ningbo Medical Centre Lihuili Hospital, Zhejiang Province, Ningbo - China.
Background:
The Non-alcoholic fatty liver disease (NAFLD) prevalence is increasing globally and is closely associated with dysregulated lipid metabolism and inflammation. However, the relationship between NAFLD and the inflammatory atherosclerosis index (IAI), which reflects these processes, is unclear.
Objectives:
To investigate the association between IAI and NAFLD in a representative sample of U.S. adults.
Methods:
This cross-sectional study included 5,309 adults from the U.S. NHANES database. Multivariate weighted logistic regression was used to assess the association between IAI and NAFLD. Restricted cubic splines explored nonlinear relationships, and ROC analysis evaluated diagnostic performance.
Results:
A total of 5,309 participants were included, of whom 37.6% had NAFLD. Obesity and metabolic abnormalities were more pronounced in the NAFLD group, and IAI levels were significantly higher (P < 0.001). Multivariate analysis demonstrated that IAI was independently and positively associated with NAFLD (OR = 1.538, 95% CI: 1.421-1.665). RCS analysis indicated a nonlinear relationship (P for nonlinearity = 0.0473), with an inflection point at IAI = 0.145. When IAI < 0.145, the risk increased steeply (OR = 2.341, 95% CI: 2.037-2.690), whereas when IAI ≥ 0.145, the increase was attenuated (OR = 1.399, 95% CI: 1.263-1.548). Subgroup analyses showed consistent results, with no significant interactions across subgroups. ROC analysis showed that IAI exhibited the best diagnostic performance (AUC = 0.722), significantly outperforming other indicators (all P < 0.001).
Conclusions:
Among U.S. adults, IAI demonstrates a strong, positive, and nonlinear association with NAFLD. These findings suggest IAI is a promising population-level marker for NAFLD, though prospective studies are required for validation.
Related Concept Videos
Inflammation
Atherosclerosis I: Introduction
Cirrhosis I: Introduction
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Atherosclerosis III: Management
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...